Atlas Trials

COVID-19 Antibody Responses in Cystic Fibrosis

Clinical trial NCT05052294 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05052294
Sponsor
University Hospital, Motol
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Cystic Fibrosis
Start date
2021-09-13
Primary completion
2025-06-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.